Literature DB >> 27166348

Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Ciorsti MacIntyre1, Neal K Lakdawala2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27166348     DOI： 10.1161/CIRCULATIONAHA.115.015085

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Surgical management of atrial fibrillation at the time of septal myectomy.

Authors:  Eduard Quintana; James L Cox
Journal:  Ann Cardiothorac Surg       Date:  2017-07

2.  Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy.

Authors:  Xiangbin Meng; Xu-Liang Wang; Zhi-Yuan Zhang; Kuo Zhang; Jun Gao; Ji-Lin Zheng; Jing-Jia Wang; Yu-Peng Liu; Jie Yang; Chen Li; Yi-Tian Zheng; Chunli Shao; Wen-Yao Wang; Yi-Da Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-04       Impact factor: 6.055

Review 3.  Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.

Authors:  Lohit Garg; Manasvi Gupta; Syed Rafay Ali Sabzwari; Sahil Agrawal; Manyoo Agarwal; Talha Nazir; Jeffrey Gordon; Babak Bozorgnia; Matthew W Martinez
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

4.  Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.

Authors:  Christopher N Toepfer; Amanda C Garfinkel; Gabriela Venturini; Hiroko Wakimoto; Giuliana Repetti; Lorenzo Alamo; Arun Sharma; Radhika Agarwal; Jourdan F Ewoldt; Paige Cloonan; Justin Letendre; Mingyue Lun; Iacopo Olivotto; Steve Colan; Euan Ashley; Daniel Jacoby; Michelle Michels; Charles S Redwood; Hugh C Watkins; Sharlene M Day; James F Staples; Raúl Padrón; Anant Chopra; Carolyn Y Ho; Christopher S Chen; Alexandre C Pereira; Jonathan G Seidman; Christine E Seidman
Journal:  Circulation       Date:  2020-01-27       Impact factor: 29.690

Review 5.  Thromboembolism in Patients with Hypertrophic Cardiomyopathy.

Authors:  Lu Liu; Zheng Liu; Xiaoping Chen; Sen He
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

6.  Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy.

Authors:  Junya Komatsu; Ryu-Ichiro Imai; Yoko Nakaoka; Koji Nishida; Shu-Ichi Seki; Toru Kubo; Naohito Yamasaki; Hiroaki Kitaoka; Sho-Ichi Kubokawa; Kazuya Kawai; Naohisa Hamashige; Yoshinori L Doi
Journal:  Circ Rep       Date:  2021-04-06

7.  Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Yoichi Imori; Hitoshi Takano; Hiroshi Mase; Junya Matsuda; Hideto Sangen; Yuki Izumi; Yukichi Tokita; Takeshi Yamamoto; Wataru Shimizu
Journal:  BMC Cardiovasc Disord       Date:  2019-12-30       Impact factor: 2.298

8.  Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors:  Toru Kubo; Yuichi Baba; Yuri Ochi; Takayoshi Hirota; Naohito Yamasaki; Kazuya Kawai; Katsuhito Yamamoto; Fumiaki Kondo; Kanji Bando; Eisuke Yamada; Takashi Furuno; Toshikazu Yabe; Yoshinori L Doi; Hiroaki Kitaoka
Journal:  ESC Heart Fail       Date:  2021-09-02

9.  Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis.

Authors:  Zetao Ma; Xizhi Wang; Qingbo Lv; Yingchao Gong; Minghong Xia; Lenan Zhuang; Xue Lu; Ying Yang; Wenbin Zhang; Guosheng Fu; Yang Ye; Dongwu Lai
Journal:  Pharmgenomics Pers Med       Date:  2021-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.